Literature DB >> 16917200

Prevention of AD: the which, when, and on whom?

Lenore J Launer1.   

Abstract

Mesh：

Year:  2006        PMID： 16917200     DOI： 10.1097/00002093-200607001-00011

Source DB:  PubMed          Journal:  Alzheimer Dis Assoc Disord        ISSN： 0893-0341            Impact factor:   2.703


× No keyword cloud information.
  4 in total

1.  Therapeutics for cognitive aging.

Authors:  Diana W Shineman; Timothy A Salthouse; Lenore J Launer; Patrick R Hof; George Bartzokis; Robin Kleiman; Victoria Luine; Jerry J Buccafusco; Gary W Small; Paul S Aisen; David A Lowe; Howard M Fillit
Journal:  Ann N Y Acad Sci       Date:  2010-04       Impact factor: 5.691

2.  Subsets of a large cognitive battery better power clinical trials on early stage Alzheimer's disease.

Authors:  Chengjie Xiong; Hua Weng; David A Bennett; Patricia A Boyle; Raj C Shah; Scot Fague; Charles B Hall; Richard B Lipton; John C Morris
Journal:  Neuroepidemiology       Date:  2014-11-05       Impact factor: 3.282

3.  Combining Multiple Markers to Improve the Longitudinal Rate of Progression-Application to Clinical Trials on the Early Stage of Alzheimer's Disease.

Authors:  Chengjie Xiong; Gerald van Belle; Kewei Chen; Lili Tian; Jingqin Luo; Feng Gao; Yan Yan; Ling Chen; John C Morris; Paul Crane
Journal:  Stat Biopharm Res       Date:  2013-01-01       Impact factor: 1.452

Review 4.  Commentary on "a roadmap for the prevention of dementia II: Leon Thal Symposium 2008." Prevention trials in persons at risk for dominantly inherited Alzheimer's disease: opportunities and challenges.

Authors:  John M Ringman; Joshua Grill; Yaneth Rodriguez-Agudelo; Mireya Chavez; Chengjie Xiong
Journal:  Alzheimers Dement       Date:  2009-03       Impact factor: 21.566
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.